Charles River Labs (CRL) PT Raised to $84 at UBS Following Strong 4Q Results

February 15, 2017 9:31 AM

UBS analyst Jonathan Groberg maintains Sell rating and raises price target on Charles River Laboratories International (NYSE: CRL) to $84 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found